ArticleBlood advances2026

Improved survival and health care use with CAR-T vs historical care in relapsed/refractory large B-cell lymphoma.

Tiana Kordbacheh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.